Corticotropin hormone assay interference: A case series

D. M. Donegan, A. Algeciras-Schimnich, O. Hamidi, W. F. Young, T. Nippoldt, I. Bancos, D. Erickson

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

Measuring the plasma corticotropin (ACTH) concentration is an important step in determining the underlying cause in patients with hypercortisolemia. Interfering substances in immunoassays can lead to erroneous results impacting clinical management. We describe a case series of 12 patients, the majority of whom were being investigated for possible Cushing's syndrome and in whom inconsistencies between the clinical picture and biochemical testing raised concerns of assay interference. ACTH assay interference resulted in falsely elevated ACTH concentrations using the Siemens Immulite assay and consequently led to additional unnecessary testing. Communication between physician and laboratory as well as appropriate investigation (including sample dilution, use of blocking antibodies and testing on an alternate platform) resulted in assay interference identification. Recognition of biochemical results which are clinically discrepant remains an essential step in patient assessment.

Original languageEnglish (US)
Pages (from-to)143-147
Number of pages5
JournalClinical Biochemistry
Volume63
DOIs
StatePublished - Jan 2019

Keywords

  • Assay interference
  • Corticotropin
  • Heterophile antibodies

ASJC Scopus subject areas

  • Clinical Biochemistry

Fingerprint Dive into the research topics of 'Corticotropin hormone assay interference: A case series'. Together they form a unique fingerprint.

  • Cite this

    Donegan, D. M., Algeciras-Schimnich, A., Hamidi, O., Young, W. F., Nippoldt, T., Bancos, I., & Erickson, D. (2019). Corticotropin hormone assay interference: A case series. Clinical Biochemistry, 63, 143-147. https://doi.org/10.1016/j.clinbiochem.2018.11.006